World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
69
Citations
17329
World Ranking
6181
National Ranking
174

Overview

Ana Martínez is affiliated with the Spanish National Research Council in Spain. Their research intersects multiple fields within medicine and biochemistry, genetics, and molecular biology, with a particular focus on molecular biology, epidemiology, infectious diseases, neurology, and pharmacology.

The scientist has contributed extensively to the following main fields of study:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these areas, Martínez has worked on several subfields, including:

  • Molecular Biology
  • Epidemiology
  • Infectious Diseases
  • Neurology
  • Pharmacology

The main topics addressed in their research include:

  • Amyotrophic Lateral Sclerosis Research
  • Cholinesterase and Neurodegenerative Diseases
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Alzheimer's disease research and treatments

Ana Martínez's publication record includes papers in a variety of scientific journals. Frequent venues for their work are:

  • Journal of Medicinal Chemistry
  • International Journal of Molecular Sciences
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccines
  • ACS Chemical Neuroscience

Recent papers authored or coauthored by Martínez include:

  • "COVID-19: Drug Targets and Potential Treatments," 2020, Journal of Medicinal Chemistry
  • "Targeting autophagy in disease: established and new strategies," 2021, Autophagy
  • "Kinase Inhibitors as Underexplored Antiviral Agents," 2021, Journal of Medicinal Chemistry
  • "Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment," 2020, Scientific Reports
  • "Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010/2011 to 2015/2016," 2020, BMC Infectious Diseases

The scientist has collaborated frequently with several coauthors, including:

  • Carmen Gil
  • Loreto Martínez-González
  • Núria Torner
  • Mireia Jané
  • Núria Soldevila

Best Publications

  • First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

    Ana Martinez;Mercedes Alonso;Ana Castro;Concepción Pérez

  • Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.

    Ana Martinez;Ana Castro;Isabel Dorronsoro;Mercedes Alonso

  • COVID-19: Drug targets and potential treatments.

    Carmen Gil;Tiziana Ginex;Inés Maestro;Vanesa Nozal

  • Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.

    Pilar Munoz-Ruiz;Laura Rubio;Esther Garcia-Palomero;Isabel Dorronsoro

  • Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors.

    Ana Castro;Ana Martinez

  • Regulation of Inflammatory Response in Neural Cells in Vitro by Thiadiazolidinones Derivatives through Peroxisome Proliferator-activated Receptor γ Activation

    Rosario Luna-Medina;Marta Cortes-Canteli;Mercedes Alonso;Angel Santos

  • Donator acceptor map for carotenoids, melatonin and vitamins.

    Ana Martínez;Miguel A. Rodríguez-Gironés;Andrés Barbosa;Miguel Costas

  • Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE

    D. Alonso;I. Dorronsoro;L. Rubio;P. Muñoz

  • Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.

    Ana Castro;Ana Martinez

  • Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.

    María Isabel Fernández‐Bachiller;Concepción Pérez;Nuria Eugenia Campillo;Juan Antonio Páez

  • Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.

    Jose A. Morales-Garcia;Rosario Luna-Medina;Sandra Alonso-Gil;Marina Sanz-SanCristobal

  • Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.

    Karumanchi V. Rao;Marwa S. Donia;Jiangnan Peng;Esther Garcia-Palomero

  • SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

    Ana Martinez;Mercedes Alonso;Ana Castro;Isabel Dorronsoro

  • Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease.

    Mark Hamann;Diana Alonso;Ester Martín-Aparicio;Ana Fuertes

  • Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.

    Ana Castro;Maria Jose Jerez;Carmen Gil;Ana Martinez

  • Structure stability of HKUST-1 towards water and ethanol and their effect on its CO2 capture properties

    J. Raziel Álvarez;Elí Sánchez-González;Eric Pérez;Emilia Schneider-Revueltas

  • The structure of Nb3O and Nb3O+ determined by pulsed field ionization–zero electron kinetic energy photoelectron spectroscopy and density functional theory

    Dong‐Sheng Yang;Marek Z. Zgierski;David M. Rayner;Peter A. Hackett

  • Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors

    Federica Prati;Angela De Simone;Angela De Simone;Paola Bisignano;Andrea Armirotti

  • Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice

    Angelo O. Rosa;Manuella P. Kaster;Ricardo W. Binfaré;Susana Morales

  • Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.

    Ana Martinez;Ana Castro

  • Hyperthermia HeLa Cell Treatment with Silica-Coated Manganese Oxide Nanoparticles

    A. Villanueva;P. de la Presa;J. M. Alonso;T. Rueda

  • Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching.

    Santiago Conde;Daniel I. Perez;Ana Martinez;Concepcion Perez

Frequent Co-Authors

José Elguero
José Elguero Spanish National Research Council
Luis M. Serra
Luis M. Serra University of Zaragoza
Annia Galano
Annia Galano Universidad Autónoma Metropolitana

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For chemistry students interested in the forensic field, exploring forensic psychology master's programs can provide a specialized pathway that blends science with criminal investigation. These programs deepen understanding of psychological principles within forensic contexts, complementing a strong chemistry foundation.

Additionally, those pursuing careers in evidence analysis and lab work might consider various forensic careers. These roles often require a solid grasp of chemical processes and lab techniques, key skills developed in chemistry studies.

Cost considerations are important when selecting programs, especially for fields adjacent to chemistry like criminal justice. Reviewing the cost of criminal justice degree can help students budget and plan their education effectively.

For those starting their journey, the best online criminal justice associate degree programs provide accessible entry points that build foundational knowledge and skills valuable in forensic and chemistry-related careers.

Best Scientists Citing Ana Martínez

Trending Scientists

Recently Published Articles